Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -4.633% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: COC(=O)c1ccc(OC(=O)CCN2C(=O)C3CCCCC3C2=O)cc1
b: COc1ccc(Cc2c(O)nc(SC)n(C(C)=O)c2=O)cc1
c: Cn1c(SCC2CCCO2)nnc1-c1ccc([N+](=O)[O-])cc1
Answer: a. COC(=O)c1ccc(OC(=O)CCN2C(=O)C3CCCCC3C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1ccc(OC(=O)CCN2C(=O)C3CCCCC3C2=O)cc1
COC(=O)c1ccc(OC(=O)CCN2C(=O)C3CCCCC3C2=O)cc1
methyl 4-[3-(1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-2-yl)propanoyloxy]benzoate